ORAMED PHARMACEUTICALS INC. (ORMP) Total liabilities 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) total liabilities at each fiscal year-end, per SEC filings.
$31.1MFY2025 · since FY2016: $16.6M → $31.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $31.1M | — |
| FY2023 | $56.7M | +477.1% |
| FY2022 | $9.8M | -19.6% |
| FY2021 | $12.2M | +4.0% |
| FY2020 | $11.8M | -23.0% |
| FY2019 | $15.3M | -6.2% |
| FY2018 | $16.3M | -16.4% |
| FY2017 | $19.5M | +17.0% |
| FY2016 | $16.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice